In severe COVID-19 patients, these may be linked to multiple factors, among them as the significant ones were the aged patients, reduced systemic oxygenation intake due to pneumonia, concomitantly increased cardiac demand, and use of ACE inhibitors (Ejaz et al., 2020). The gene discussed is ACE; the disease is pneumonia.